These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 37608608

  • 1. Biomarkers in congenital adrenal hyperplasia.
    Bacila IA, Lawrence NR, Badrinath SG, Balagamage C, Krone NP.
    Clin Endocrinol (Oxf); 2024 Oct; 101(4):300-310. PubMed ID: 37608608
    [Abstract] [Full Text] [Related]

  • 2. Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia.
    Ng SM, Stepien KM, Krishan A.
    Cochrane Database Syst Rev; 2020 Mar 19; 3(3):CD012517. PubMed ID: 32190901
    [Abstract] [Full Text] [Related]

  • 3. Hormonal circadian rhythms in patients with congenital adrenal hyperplasia: identifying optimal monitoring times and novel disease biomarkers.
    Debono M, Mallappa A, Gounden V, Nella AA, Harrison RF, Crutchfield CA, Backlund PS, Soldin SJ, Ross RJ, Merke DP.
    Eur J Endocrinol; 2015 Dec 19; 173(6):727-37. PubMed ID: 26340969
    [Abstract] [Full Text] [Related]

  • 4. Monitoring of therapy in congenital adrenal hyperplasia.
    Dauber A, Kellogg M, Majzoub JA.
    Clin Chem; 2010 Aug 19; 56(8):1245-51. PubMed ID: 20558634
    [Abstract] [Full Text] [Related]

  • 5. Measurement of Salivary Adrenal-Specific Androgens as Biomarkers of Therapy Control in 21-Hydroxylase Deficiency.
    Bacila I, Adaway J, Hawley J, Mahdi S, Krone R, Patel L, Alvi S, Randell T, Gevers E, Dattani M, Cheetham T, Kyriakou A, Schiffer L, Ryan F, Crowne E, Davies JH, Ahmed SF, Keevil B, Krone N.
    J Clin Endocrinol Metab; 2019 Dec 01; 104(12):6417-6429. PubMed ID: 31361321
    [Abstract] [Full Text] [Related]

  • 6. Steroid 17-Hydroxyprogesterone in Hair Is a Potential Long-Term Biomarker of Androgen Control in Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.
    Auer MK, Krumbholz A, Bidlingmaier M, Thieme D, Reisch N.
    Neuroendocrinology; 2020 Dec 01; 110(11-12):938-949. PubMed ID: 31711056
    [Abstract] [Full Text] [Related]

  • 7. A Phase 2, Multicenter Study of Nevanimibe for the Treatment of Congenital Adrenal Hyperplasia.
    El-Maouche D, Merke DP, Vogiatzi MG, Chang AY, Turcu AF, Joyal EG, Lin VH, Weintraub L, Plaunt MR, Mohideen P, Auchus RJ.
    J Clin Endocrinol Metab; 2020 Aug 01; 105(8):2771-8. PubMed ID: 32589738
    [Abstract] [Full Text] [Related]

  • 8. Reverse circadian glucocorticoid treatment in prepubertal children with congenital adrenal hyperplasia.
    Dubinski I, Bechtold Dalla-Pozza S, Bidlingmaier M, Reisch N, Schmidt H.
    J Pediatr Endocrinol Metab; 2021 Dec 20; 34(12):1543-1548. PubMed ID: 34523293
    [Abstract] [Full Text] [Related]

  • 9. The Application of Principal Component Analysis on Clinical and Biochemical Parameters Exemplified in Children With Congenital Adrenal Hyperplasia.
    Ljubicic ML, Madsen A, Juul A, Almstrup K, Johannsen TH.
    Front Endocrinol (Lausanne); 2021 Dec 20; 12():652888. PubMed ID: 34531821
    [Abstract] [Full Text] [Related]

  • 10. Urinary steroidomic profiles by LC-MS/MS to monitor classic 21-Hydroxylase deficiency.
    Pussard E, Travers S, Bouvattier C, Xue QY, Cosson C, Viengchareun S, Martinerie L, Lombès M.
    J Steroid Biochem Mol Biol; 2020 Apr 20; 198():105553. PubMed ID: 31778802
    [Abstract] [Full Text] [Related]

  • 11. Indicators of adult height outcome in classical 21-hydroxylase deficiency congenital adrenal hyperplasia.
    Muirhead S, Sellers EA, Guyda H, Canadian Pediatric Endocrine Group.
    J Pediatr; 2002 Aug 20; 141(2):247-52. PubMed ID: 12183722
    [Abstract] [Full Text] [Related]

  • 12. Correlation between androstenedione and 17-hydroxyprogesterone levels in the saliva and plasma of patients with congenital adrenal hyperplasia.
    Juniarto AZ, Goossens K, Setyawati BA, Drop SL, de Jong FH, Faradz SM.
    Singapore Med J; 2011 Nov 20; 52(11):810-3. PubMed ID: 22173250
    [Abstract] [Full Text] [Related]

  • 13. [Congenital adrenal hyperplasia due to 21-hydroxylase deficiency--management in adults].
    Ambroziak U, Bednarczuk T, Ginalska-Malinowska M, Małunowicz EM, Grzechocińska B, Kamiński P, Bablok L, Przedlacki J, Bar-Andziak E.
    Endokrynol Pol; 2010 Nov 20; 61 Suppl 1():7-21. PubMed ID: 22127631
    [Abstract] [Full Text] [Related]

  • 14. Interrelationships among cortisol, 17-hydroxyprogesterone, and androstenendione exposures in the management of children with congenital adrenal hyperplasia.
    Sarafoglou K, Zimmerman CL, Gonzalez-Bolanos MT, Willis BA, Brundage R.
    J Investig Med; 2015 Jan 20; 63(1):35-41. PubMed ID: 25386671
    [Abstract] [Full Text] [Related]

  • 15. 11-oxygenated androgens and their relation to hypothalamus-pituitary-gonadal-axis disturbances in adults with congenital adrenal hyperplasia.
    Auer MK, Paizoni L, Neuner M, Lottspeich C, Schmidt H, Bidlingmaier M, Hawley J, Keevil B, Reisch N.
    J Steroid Biochem Mol Biol; 2021 Sep 20; 212():105921. PubMed ID: 34058329
    [Abstract] [Full Text] [Related]

  • 16. [Determination of serum steroids in monitoring therapy of congenital adrenal hyperplasia].
    Xiao HW, Ma HM, Su Z, Du ML, Li YH, Chen HS, Chen QL.
    Zhonghua Er Ke Za Zhi; 2012 Apr 20; 50(4):301-7. PubMed ID: 22801236
    [Abstract] [Full Text] [Related]

  • 17. Crinecerfont Lowers Elevated Hormone Markers in Adults With 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia.
    Auchus RJ, Sarafoglou K, Fechner PY, Vogiatzi MG, Imel EA, Davis SM, Giri N, Sturgeon J, Roberts E, Chan JL, Farber RH.
    J Clin Endocrinol Metab; 2022 Feb 17; 107(3):801-812. PubMed ID: 34653252
    [Abstract] [Full Text] [Related]

  • 18. Androgen excess is due to elevated 11-oxygenated androgens in treated children with congenital adrenal hyperplasia.
    Kamrath C, Wettstaedt L, Boettcher C, Hartmann MF, Wudy SA.
    J Steroid Biochem Mol Biol; 2018 Apr 17; 178():221-228. PubMed ID: 29277706
    [Abstract] [Full Text] [Related]

  • 19. Adiponectin levels are high in children with classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency.
    Völkl TM, Simm D, Körner A, Kiess W, Kratzsch J, Dörr HG.
    Acta Paediatr; 2009 May 17; 98(5):885-91. PubMed ID: 19236311
    [Abstract] [Full Text] [Related]

  • 20. Current and novel approaches to children and young people with congenital adrenal hyperplasia and adrenal insufficiency.
    Webb EA, Krone N.
    Best Pract Res Clin Endocrinol Metab; 2015 Jun 17; 29(3):449-68. PubMed ID: 26051302
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.